| abstract |
The present disclosure provides compounds represented by Formula I:n nand the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R 1 , R 2a , R 2b , R 3 , R 4 , Ar, L, X, Y, and B are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat a condition or disorder responsive to degradation of BET bromodomains such as cancer. |